New Guidelines to Prevent SCD: What You Need to Know

Slides:



Advertisements
Similar presentations
An ICD for every CRT patient ?
Advertisements

Charmaine J. Palafox, MD. Approx. 50% of CHD deaths occurs as sudden cardiac arrest.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA/ESC 2006 Guidelines for Management of Patients.
Sudden Cardiac Arrest Morhaf Ibrahim, MD, FHRS Electrophysiology.
Applying the New Multiple Sclerosis Guidelines to Clinical Practice
The Patient Experience With Systemic Lupus Erythematosus
SAVOR-TIMI 53 Summary SAVOR-TIMI 53: Primary End Point of CV Death, MI, Ischemic Stroke.
Acute Hypertension Management Optimizing Door-to-Needle Time in Ischemic Stroke.
Current State of Hyperkalemia Management
NOACs for Cancer-Associated Thrombosis:
Duration of Dual Antiplatelet Therapy Post-ACS: Lessons From Clinical Trials.
Starting Strong: Initial Evaluation of the Patient With HCV
Know Your ABCs: Antiplatelet Therapy, Benefits/Bleeding, and Cardiac Surgery State of the Art: The Role of Antiplatelet Therapy in the Cardiac Surgical.
Risk Stratification in PAH: What Do the Latest Data Suggest?
Preventing SCD With a WCD: Reviewing the Results of the VEST Trial
Addressing Patients at High Risk for SCA
Dual Goals for the Management of Stable Ischemic Heart Disease (SIHD)
Update on Clostridium difficile Infection
Duration of Dual Antiplatelet Therapy Post-ACS: Lessons from Clinical Trials.
Patient Presentation Patient’s Changing Condition Multiple Considerations To Balance.
Neoadjuvant Therapy in HER2-Positive Breast Cancer
Statins and the Elderly Patient
It’s Elementary.
How and When to Decide on Revascularization in Stable Ischemic Heart Disease.
Terms of Use. Terms of Use.
Statins and New-Onset Diabetes REAL Updates and Clinical Implications
Time to Take Gout Seriously
Updates in Preventing Skeletal-Related Events in Multiple Myeloma
Are We Closer to Personalized Medicine in MS?
Statins and Glucose Metabolism: Are All Agents Alike?
AF and PCI in Practice.
Personalizing Statin Therapy in Patients With HIV
Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?
Avoiding Opioid Overuse: Guideline-Based Management of Osteoarthritis
A Case-based Approach to RSV Disease
VTE in Cancer.
Reversal Strategies for VKA: Truths and Misconceptions
OTC NSAID Use in Patients With OA and CV Disease
Risk Stratification in CAD and PAD
Remote Patient Management:
A PCP's Guide to Dyslipidemia
Aspirin in Cardioprevention:
Exploring Statin Intolerance
Atrial Fibrillation.
Updated Guideline Recommendations for the Definitive Diagnosis of Unexplained Syncope.
Aspirin and Cardioprevention in 2018
Identifying High-Risk AF Patients
Duration of Dual Antiplatelet Therapy Post-ACS: Lessons from Clinical Trials.
Definition of Elderly. Advanced Age and CV Risk: To Start or Not to Start a Statin in Older Patients?
Factor Xa Inhibitors in PAD
Managing HF in Primary Care
Evaluating BTK Inhibitors in CLL
Latest Lipid Guidelines in Perspective
Improving Effective Basal Insulin Use in Clinical Practice
Perspective on the Multidisciplinary Management of PAH
Relative risks of clinical events for primary and secondary prevention with selected drugs Thomas A Gaziano, et al. Lancet 2006; 368:
Clinical Challenges and Updates in Managing Seizure Clusters
Practical Tools for SCA Screening
An Unmet Need.
Prioritizing Prevention of HPV-Related Disease
Key Considerations in Diagnosing the Flu
Jordan S. Leyton-Mange et al. JACEP 2017;j.jacep
Omega-3s vs Pure EPA in Clinical Practice
Rethinking Risk Stratification for Nonischemic HF:
Extraordinary Cases in Stroke Prevention
Disease Activity Cutoffs for ACR-Recommended RA Disease Activity Measure
Shared-Decision Making in Dyslipidemia
Case-Based Look at Hyperkalemia Identification, Diagnosis, and Management.
The Power of As-Treated Analyses
Translating Data From Trial to Practice
Presentation transcript:

New Guidelines to Prevent SCD: What You Need to Know

Goals

SCD Death -- Hot Topic

Key Updates From the New Guidelines

Key Updates From the New Guidelines (cont)

Key Updates From the New Guidelines (cont)

Arrhythmia Suppression

Inadequate Vascular Access or at High Risk for Infection

First-Degree Relatives With SCD

Shared Decision-Making

Risk Stratification

Risk Stratification and EF

SCD Is the First Recognized Clinical Event Vast Majority of Patients

Determining Risk for Ischemic vs Nonischemic Patients

2017 AHA/ACC/HRS Guidelines Risk for Ventricular Arrhythmias

Primary Prevention of SCD in Patients With NICM

Primary Prevention of SCD in Patients With Ischemic Heart Disease

When to Consider a WCD Patient Types

WCD Class IIb Recommendation

Well-Coordinated Multidisciplinary Teams

Shared Decision-Making

Key Takeaways

Abbreviations

Abbreviations (cont)